Why am I still experiencing shortness of breath one month after having a stent procedure, and what should I do?

Shortness of breath one month after stent placement may be related to factors such as medication, heart failure, or ischemic cardiomyopathy, and requires symptomatic treatment. Specific analyses are as follows:

1. Medication factors

If ticagrelor has been taken after stent placement, long-term use of this drug may cause bronchospasm and lead to shortness of breath. If the symptom is significant, the drug should be discontinued promptly.

2. Heart failure

This is a relatively common clinical condition involving circulatory dysfunction. If a patient already has this condition, abnormal cardiac systolic and diastolic functions may occur after stent placement, resulting in shortness of breath. Treatment should actively follow medical advice using medications such as spironolactone tablets, hydrochlorothiazide tablets, and furosemide tablets to promote recovery.

3. Ischemic cardiomyopathy

This is a complex clinical syndrome that causes vascular narrowing. After stent placement, the narrowing may worsen and trigger shortness of breath. Treatment should strictly follow medical guidance with drugs such as metoprolol tartrate tablets, bisoprolol fumarate tablets, and verapamil hydrochloride sustained-release tablets.

In addition to the above factors, shortness of breath could also result from pulmonary infection, thrombosis, myocardial infarction, or other causes. Upon experiencing discomfort, patients should promptly visit a正规 hospital for evaluation to determine the underlying cause and receive appropriate, guideline-based medical treatment.